In: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006.


No information is available on the use of lefamulin during breastfeeding. The manufacturer recommends that mothers should avoid breastfeeding during treatment and for 2 days after the final dose. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Publication types

  • Review